Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

LANXESS India donates six ventilators to hospitals in Thane

LANXESS India donates six ventilators to hospitals in Thane

To help combat the novel coronavirus pandemic in the country, specialty chemicals company LANXESS donated six ventilators worth over INR 1 crore to Kaushalya Medical Foundation Trust Hospital and Bethany Hospital in Thane. Both hospitals have been provided with three ventilators each. The donation was done as part of the companyโ€™s CSR initiative for 2020-2021.

The hospitals, located in Thane will use these ventilators for treatment of patients from neighboring areas. LANXESS has been proactively collaborating with authorities and medical institutions in its concerted efforts to help local community in fighting the pandemic.

In the past months, LANXESS India has undertaken various initiatives with regards to minimizing the impact of COVID-19. This includes financial support of INR 2 crore to the Prime Ministerโ€™s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES) and donation of relief material worth INR 30 lakhs to local authorities in the states of Maharashtra, Madhya Pradesh and Gujarat. This also included collaboration with the Akshaya Patra Foundation, through which the company provided over 30,000 free meals to the needy.

LANXESS helped in reducing cross contamination of coronavirus by donating 1 tonne of its highly effective surface disinfectant, Rely+Onโ„ข Virkonโ„ข to the BMC and TMC through the Government of Maharashtra relief co-ordination center.

Dr. Sameep Sohoni, MS Ortho, DNB Ortho, FICS(USA), Consultant Orthopaedic and Joint Replacement Surgeon, Kaushalya Medical Foundation Trust Hospital said, โ€œWe are grateful to LANXESS India for donating these ventilators to us as it is the most important equipment which is required in the management of Covid patients in ICU and who have low oxygen levels. We thank the management of LANXESS India for this support and are sure that this donation would help us save more lives and will also give a moral boost to our team that has been working tirelessly for Covid patients for the past 5 months.โ€

Thanking LANXESS for its support, Vijay Lakka, COO, Bethany Hospital said, โ€œLANXESS Indiaโ€™s donation of these high-end ventilators at this juncture enables our hospital to try save more lives, especially when there is a huge shortage globally for critical-care equipment. These specific ventilators equipped with High-flow nasal oxygen (HFNO) therapy can provide respiratory support for patients with acute hypoxemic respiratory failure and can also prevent subsequent intubation in this pandemic situation. Thank you for being part of our community and stepping up to do what very few have accomplished in these difficult times.โ€

Neelanjan Banerjee, Vice Chairman and Managing Director, LANXESS India commented, โ€œIn these challenging times, medical institutions and their infrastructure have witnessed tremendous stress. Having identified this as a critical area that needs immediate attention, we have made a humble attempt in easing out the pressure. Our contribution is specially aimed at making critical care available and enhancing life-saving infrastructure in these hospitals. We are hoping to make a significant difference in our society and will continue to help the community at large in fighting the pandemic.โ€

About Kaushalya Medical Foundation Trust Hospital

Kaushalya Medical Foundation Trust Hospital has been serving people of Thane city and district since 2002 at its 100 bed tertiary care facility in Thane. The hospitalโ€™s journey as a dedicated Covid hospital began on 17th April 2020 and till now it has treated more than 1100 Covid-19 patients from Thane city and neighbouring areas.

About Bethany Hospital

Bethany Hospital owned and managed by Bethany Trust was found in the year 1997 with the core belief that every life is a precious Gift of God and deserves our utmost attention. At this 190 bedded tertiary care facility during this COVID-19 Pandemic more than 900 patients were treated for COVID-19 and the Hospital continues to serve the needy at large.

About LANXESS

LANXESS is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,300 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Healthcare Informatics: The power of efficient workflows

At a glance

  • An efficient workflow can remove variation from the care process and support clinicians to deliver quality care.
  • Through advanced technologies, departments can reduce waste and save time, to benefit the patient experience.
  • Informatics can put the right data in the right place at the right time to enable clinicians to do their work.

An efficient workflow transforms the patient journey by reducing time and waste. It is the difference between a good or bad patientโ€”or staffโ€”experience. And it unites data, images and specialties to improve productivity, save time and deliver quality care.

Hear what your peers are saying about the role of efficient workflows in delivering quality care

These healthcare IT leaders discuss how efficient workflows reduce waste in the care process, save clinician time and enhance the patient experience.

Mr. Benedict Tan discusses how workflow design can deliver a more valuable patient experience

For too long, I think we have been pretty much influenced by the industrial revolution where everything is very efficient from within the hospital and a lot of times it’s within a specific department or a team. But times have changed. I think the patients now deserve to be provided with better services and provided better care.โ€

Mr. Benedict Tan
Chief Digital Strategy Officer, SingHealth, Singapore

Dr. Ronnie Ptasznik speaks on the important role a good workflow plays in removing variation in a clinicianโ€™s work

A workflow is a series of tasks and processes that have to happen in a predetermined order to get a job done. It’s a roadmap that takes you from nowhere to where you need to be. In healthcare, we’re dealing with a patient and every patient is unique.โ€

Dr. Ronnie Ptasznik
Chief Medical Information Officer, Monash Health, Australia

Mr. Leo Bodden discusses how efficient workflows reduce the time a clinician spends managing technology

When you think about any workflow, there are many steps in that pipeline. Today there are a number of steps, many steps, that could be eliminated from any given workflow when you think about any of the services that are provided in healthcare.โ€

Mr. Leo Bodden
VP & Chief Technology Officer, New York-Presbyterian Hospital, United States

Mr. Jacques Rossler examines the role of clinically efficient workflows in care pathway management

A clinically efficient workflow is a workflow where we can really process our patient via care pathways that are advanced, based on the best practices, based on evidence-based medicine, where the patient gets the best care at the best moment.โ€

Mr. Jacques Rossler
Chief Information Officer, UCL Saint-Luc, Belgium.

Mr. Henning Schneider discusses the role of informatics in supporting a first-time-right diagnosis

I think it’s really, really important to understand when you work, discuss, or when you do digital workflows, you are not taking away the nurse or the doctors. You always support them with digital tools, with data, and the right data in the right place at the right moment. This is the most important thing that IT has to do.โ€

Mr. Henning Schneider
Chief Information Officer, Asklepios Hospital Group, Germany


Healthcare informatics โ€“ Illuminate a new path through the care continuum

Learn how Philips helps healthcare IT leaders bring to life their vision of precision care.
For more information, Click Here

Don’t Be a Victim of These 3 Forms of Medical Malpractice

Don't Be a Victim of These 3 Forms of Medical Malpractice

Doctors occupy a very important position in every community. People go to them whenever they are sick or injured, hoping that they can help them heal with their expertise. It is precisely because of this that medical training is long, meticulous, and expensive. Not just anyone can become a physician. Those who successfully graduate from medical schools have proven to be intelligent, detail oriented, and really hard working.

Itโ€™s important to remember that training never really stops for doctors. Medicine is a very dynamic field, and our general understanding of illnesses, how they propagate, and how they are treated changes by the day. To be effective in their roles, doctors must never stop learning.

When the lives of patients are involved, there should be no room for mistakes. However, doctors are only human, and sometimes have lapses in judgment. Of course, being the aggrieved party, patients have all the rights to sue. According to a Jackson Personal Injury Lawyer, you should get the help of a competent attorney in filing a case against an erring medical practitioner so you get properly compensated.

Errors in diagnosing

Itโ€™s usually not very easy for us to determine whatโ€™s wrong with our bodies when thereโ€™s a problem. We only know that some parts feel painful or tired, or feel our temperature rising. In order to make sense of the symptoms, we need the expertise of a licensed physician.

Proper diagnosis is necessary if we are to heal properly. If the doctor fails to see that the symptoms are a result of a more serious illness, we may be in big trouble. Oftentimes, this leads to an unabated worsening of the underlying condition, making life more difficult for us patients.

There are also times when doctors accurately see that there is an underlying illness, but they fail to diagnose it properly, leading to additional complications.

Prescription errors

When we see a doctor, we often leave with a prescription from them, detailing the medication we should take, along with when and how to take them. With no knowledge in medicine, most of us trust that the doctor knows what theyโ€™re giving us. Because of this, any error in the prescription can easily lead to ugly consequences.

Surgical mistakes

Having surgery sounds like a major and rare thing, but they are actually common in Mississippi and the rest of the U.S. People go under the knife for various reasons, from cyst removals to bodily enhancements.

Surgical errors usually come in the form of lacerations on the wrong part of the body. There are also a lot of documented cases where medical objects are left inside the patientโ€™s body, causing complications that can endanger a patientโ€™s life.

Medical malpractice sounds like an impossibility, but it is actually more common than many of us are willing to admit. Hence, it pays to never let our guards when we consult with doctors.

How to Prepare for a Spine Surgery

How to Prepare for a Spine Surgery

Almost everyone who is lined up for surgery tends to get a bit nervous about how their operation will turn out. However, contrary to popular belief, the success of your operation doesnโ€™t solely rely on the knowledge and expertise of your surgeon. What you do with your body before the surgery will also help contribute to a seamless and successful procedure. In line with this, if you are bound to have spine surgery soon, below are some things that you can do to prepare.

Pre-surgical Instructions

It is most likely that your doctor will provide pre-surgical instructions a couple of days before your surgery. It is of utmost importance that you follow all that your doctor will tell you to do. Before you arrive at this point, it is a wise move to raise any questions that you have about your condition to your doctor during your pre-surgical consultation. The medical experts behind Endoscopic Spine Academy suggest that you try and become an open book because your doctor is not there to judge you, rather, they are there to help you. After all, if you receive the answers to your questions, there is a great chance that you become more confident in pushing through with the surgery.

Diet

The choices you make when it comes to the food that you take in play a significant role in terms of how you will be able to handle the surgical procedure, as well as its aftermath. In line with this, exert the extra effort to reach your ideal weight weeks before your surgery. Lose or put on some weight if necessary. Maximize nutrients such as protein, calcium, vitamin D, iron, and fiber in your diet to boost your immunity and guard yourself against potential infection following the surgical procedure.

Exercise

Engaging in the physical activities that you can do before your spine surgery can strengthen your muscles, particularly those that support your spine. It can also push oxygenated blood to your spine, keeping it healthy. In this case, your body will be able to respond better to the trauma of the surgery. Just keep in mind that you need to consult with your surgeon regarding the exercises that you can perform to improve your physical condition rather than otherwise.

Psychological Preparations

Aside from preparing physically, you also need to prepare mentally before your surgery. True enough, getting on the operating table may prove to be nerve-wracking, but you need to combat your fears if you want to feel better. When you are mentally prepared, you will experience less anxiety and stress before, during, and after your operation. This will also pave the way for you to recover faster.

To wrap things up, there are several things that you can do to ensure that you will have successful spine surgery. One is by preparing for it by following pre-surgical instructions, diet, and exercise, as well as bracing yourself mentally. Rest assured that your surgeon will also do everything in their power to ensure that your medical condition is addressed and your normal body functions are restored after the procedure.

7 Important Reasons Why Society Needs to Improve Women’s Health

Women are undeniably the cornerstones of society. Their influence can be seen everywhere, including previously male-dominated fields. Unfortunately, many of them still get exposed to continuous discrimination and inequality. Consequently, their mental and physical health sees a decline, primarily because of the governmentsโ€™ neglect of their care. Thankfully, people are starting to stand up for womenโ€™s rights and bodily autonomy. Society has finally come to realize that denying women access to healthcare can ruin society. We should work towards improving womenโ€™s health for multiple reasons.

1. Reducing Risk of STDs

Women are at a huge risk of getting serious illnesses because of unprotected sexual activities. Many lack the right education that can protect them from infection.HIV and Hepatitis C are two of the most common transmissible diseases through blood and other body fluids. Some forms of protection can lower the risk of infection; however, the most efficient way of being safe is for women to only have intercourse with people who have recently been tested. Moreover, domestic violence cases should be taken more seriously, while trafficking is another threat that many women face. While prevention is better than cure, it is hard to keep up with the spread of highly infectious diseases or to put an end to all trafficking crimes. This is why we should work on normalizing getting treated for STDs to ensure that the patients and people that come in contact with them are safe, while also paying attention to the ways we can educate women and girls on how to recognize potentially dangerous situations that endanger their lives, such as underage sex work and trafficking.

2. Economic Growth

Women are a valuable asset to any country, and as such womenโ€™s health is directly proportional to economic growth. Now more than ever, they are dominating different work fields and are proving to be even greater than their male counterparts in some jobs. If womenโ€™s health deteriorates, this will result in a decreased number of working women, which in turn affects the economy. Countries that provide equal medical care have a better standard of living.

3. Confidence Boosts Productivity

Aside from medical care, plastic surgery, and aesthetic procedures, in general, have been on the rise. Interestingly, this is also accompanied by a significant boost in productivity. Studies suggest that because aesthetic procedures boost a womanโ€™s confidence, this in turn affects the average womanโ€™s productivity levels. Thatโ€™s why doctors at MyVivaa.com stress on the importance of normalizing cosmetic procedures such as body sculpting and varicose veins removal.

4. Decreases Numbers of Orphans

The lack of medical attention for women has resulted in an abnormal increase in death rates, especially among pregnant women who die of post-mortem fever. That happens due to the inhumane environment that those ladies give birth in, and the absence of postoperative care. When a mother dies, it impacts the lives of her orphaned children. Without a motherโ€™s nurturing care, children may not have a chance of becoming the best version of themselves. As a result, many children end up in foster homes, and not all of them are lucky enough to find a loving family to care for them. Working towards bettering womenโ€™s health care can save women as well as childrenโ€™s lives.

5. Application of Demographic Dividend

Modern science stresses on birth control. It states that by planning pregnancies, the economy will flourish. This phenomenon is called the demographic dividend. Unfortunately, in some regions, there is not enough health awareness about contraceptives. Women either consume inadequate doses or avoid taking the medication altogether. If birth gets organized in addition to providing citizens with labor opportunities, the country will witness increased productivity and fewer unemployment cases.

6. Raising Better Youth

Letโ€™s be honest, a motherโ€™s influence on her children is too huge to be neglected. Thatโ€™s why a womanโ€™s mental health is of utmost necessity. Unfortunately, females are more susceptible to depression, anxiety, and other disorders. The instability of hormones due to difficult pregnancies and their compromised position in society can make them more prone to developing serious mental health issues. Thankfully, mental illnesses are now getting more acknowledged. This will pave the way for

7. The World Becomes Connected

Nowadays, the world is witnessing a womenโ€™s revolution. They are fighting to take back their rights and reach equality. The countries that are concerned with this issue are connecting more with each other. They have a common cause uniting them in the face of the patriarchy and the ancient customs and traditions. Developing countries are trying to improve womenโ€™s health to cope with the world as well. Treating women as the lesser gender will lead to nothing but failure. There are countless benefits of providing high-quality healthcare to women, not least of which is paving the way for a better future for society as a whole. Thankfully, society has been paying more medical attention to women and educating them on everything from safe sex to looking after their mental wellbeing, and this is precisely why todayโ€™s women have successfully held their own in previously male-dominated fields.

Sanofi partners with Health2Sync to deliver digital therapeutics in diabetes

Sanofi partners with Health2Sync to deliver digital therapeutics in diabetes

Health2Sync, a digital health startup based in Taiwan, specializing in diabetes management, has entered into a partnership with Sanofi, a biopharmaceutical company focused on providing different healthcare solutions including diabetes.

Through this partnership, Health2Sync becomes one of the Sanofi Diabetes Digital Healthcare Ecosystem partners, the two companies aim to apply the digital solution provided by Health2Sync in 300 clinics and hospitals nationwide certified by Taiwan Diabetes Shared Care Network over the next 3 years to improve diabetes care and management locally, as well as to accelerate digital adoption and transformation for clinics and hospitals.

As part of the partnership, Health2Sync will provide patient management software for healthcare professionals and a mobile app for patients in 300 Sanofi-contracted clinics and hospitals, to realize an integrated and digitized diabetes management. The ultimate goal is to improve patients’ understanding of insulin, increase glucose control and raise the insulinization rate in Taiwan. Health2Sync’s analytics platform will assist doctors in real-time with decision making, treatment planning, and generating insights based on the health data collected with patient consent. The solution will help identify patients suited for insulin initiation and facilitate insulin titration for healthcare providers.

“Health2Sync’s solution brings a new definition to the chronic disease care loop, thanks to seamless data collection, real-time analytics, and ultimately, timely medical intervention. With our focus on digital therapeutics, there couldn’t have been a better market than Taiwan as a start, thanks to the local initiatives and robust medical practice. Our commitment to both empower patients and lessen the burden of the cost of complications arising from diabetes will be further exemplified in this partnership,” said Ed Deng, Co-founder & CEO of Health2Sync.

Moving forward, Sanofi and Health2Sync plan to further collaborate in bringing innovative digital therapeutics solutions to patients and healthcare professionals in Taiwan and other markets.

Baxter Announces Exclusive Distribution Agreement with bioMerieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.

Baxter Announces Exclusive Distribution Agreement with bioMerieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.

Baxter International Inc., a global leader in acute care, announced a distribution agreement with bioMรฉrieux, a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test. The NEPHROCLEARTM CCL14 test is currently in development for use in assessing the risk of developing persistent severe acute kidney injury (AKI). The agreement is part of a previously announced collaboration between Baxter and bioMรฉrieux to improve identification and treatment of AKI. Financial terms of the agreement were not disclosed.

As part of the agreement, Baxter will be bioMรฉrieux’s exclusive distributor of the NEPHROCLEARTM CCL14 test in Europe and the U.S. following regulatory approval and launch in both markets. Baxter and bioMรฉrieux will share in-country commercialization, while bioMรฉrieux will retain control over the regulatory approval process. Incorporating new diagnostic products into Baxter’s Acute Therapies portfolio advances the companyโ€™s efforts to support overall patient management by providing solutions that enable efficiencies in critical care.

“Baxter’s agreement with bioMรฉrieux will allow us to introduce a new diagnostic offering to our Acute Therapies portfolio and offer clinicians a meaningful tool as they manage the complexities of AKI in their patients,” said Reaz Rasul, general manager of Baxter’s Acute Therapies business.

AKI is a potentially life-threatening condition where the kidneys suddenly stop working, often as the result of illness, trauma or infection. The sudden loss of kidney function leads to the accumulation of toxins and fluid in the blood that, if left untreated, may lead to death. AKI is an increasingly common complication of acute illnesses in intensive care units and hospitals.1,2,3 The ability to predict persistent severe AKI could help physicians determine which patients are likely to recover on their own and which patients may require more intensive management, including evaluation of renal replacement therapy (“dialysis”) to replace the function of the kidneys.4 Currently, physicians are evaluating the likelihood of renal recovery and making decisions on when to initiate renal replacement therapy with conventional markers such as creatinine and urine output, which have well-known limitations.

“bioMรฉrieux continues to focus on high-medical-value diagnostics which directly benefit patients and improve their healthcare. The development of the NEPHROCLEARTM CCL14 test is consistent with our mission to aid in the care of individuals with acute medical and critical conditions like AKI and complements our existing pioneering assays for these types of patients such as procalcitonin (PCT) and NEPHROCHECKยฎ,” said Mark Miller, executive vice president and chief medical officer at bioMรฉrieux.

Role of CCL14 Biomarker in Predicting Persistent AKI

A recent study published in Intensive Care Medicine found that urinary CCL14 (Cโ€“C motif chemokine ligand 14), the novel biomarker measured by the NEPHROCLEARTM CCL14 test, is the most predictive of persistent stage 3 AKI, the most severe form of AKI,5 when compared with other AKI biomarkers (NGAL, CHI3L1, L-FABP, Cystatin C, Proenkephalin, KIM-1 and IL-18).6 The multi-center international prospective observational study, titled “Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study,” enrolled 364 patients in the intensive care unit with moderate or severe AKI (KDIGO stage 2 or 3), of whom 331 were available for the primary analysis. In the analysis cohort, 110 patients (33%) met the criteria for persistent stage 3 AKI.

The study considered a broad set of potential biomarkers that were measured in urine and/or plasma by technicians blinded to clinical data. The study authors used the area under the receiver operating characteristic curve (AUC), which summarizes the overall accuracy of a diagnostic test, to assess the predictive ability of the biomarkers. They found that the CCL14 biomarker had an AUC (95% CI) of 0.83 (0.78โ€“0.87),6 which can be considered excellent7 and was significantly (p<0.05) greater than values for the other biomarkers tested.6

Accumen Launches MyBloodHealth, a Virtual Anemia Management Software Solution for the Perioperative Patient

Accumen Launches MyBloodHealth, a Virtual Anemia Management Software Solution for the Perioperative Patient

MyBloodHealthยฎ develops an end-to-end care plan for the perioperative patient, designed to help manage anemia in a simple, efficient, cost-effective way.

Accumen Inc. is helping healthcare get better, faster. Today the company launched its first software-as-a-service (SaaS) solution, MyBloodHealthยฎ, a hospital-based telehealth anemia management program with both perioperative and comprehensive blood management options. The product connects all providers involved in a patientโ€™s care directly through the health systemโ€™s electronic health record system, making it an easy-to-use resource in the care continuum.

MyBloodHealth has been used to help manage the care of more than 7,000 patients prior to acquisition of the product by Accumen in 2019. The last year has been spent bolstering the softwareโ€™s capabilities as a telehealth platform. Todayโ€™s release of MyBloodHealth allows for natural integration with multiple platforms to connect seamlessly with any health systemโ€™s EHR resource and clinical workflow. Outcomes to date have resulted in transfusions in less than 2% of patients enrolled in MyBloodHealth, compared to the 30% of patients that typically require a transfusion in the operative setting, as well as fewer post-operative complications.1

โ€œI am very excited to introduce MyBloodHealth to hospitals and health systems nationally. This clinician-created patient blood management solution includes personalized care plans, analytics, and training all on a virtual platform. MyBloodHealth has already proven to reduce healthcare costs through a combination of length of stay reductions, new revenue from infusion medications and reduced blood utilization,โ€ said BG Porter, Accumenโ€™s chief executive officer.

โ€œMyBloodHealth can also significantly reduce a patientโ€™s hospital stay through effective perioperative anemia management. This is an advantage for both the health system and patient in todayโ€™s COVID world. The program is reimbursable and supports bundled payment program success. It also provides hospitals with appropriate measures to track key patient blood management performance and certification metrics, such as adherence to evidence-based transfusion guidelines and percentage of patients screened for anemia which is a standard of The Joint Commission. In our new world of telehealth, MyBloodHealth can add anemia management as standard of patient care for any complex surgery,โ€ said Jason Carney, vice president of Accumenโ€™s Anemia Management Business Unit.

About Accumen Inc.

At Accumen, our focus is helping healthcare get better, faster. Accumen is a technology-enabled organization that partners with hospital, health system, commercial laboratory, and payer clients to provide strategic solutions and services that deliver sustainable performance improvements. Our offerings include lab and imaging transformation, consulting, supply chain optimization, lab outreach, 3D post-processing, patient blood management, test utilization, anemia management, and clinical data exchange. Accumenโ€™s offerings enable our clients to achieve and exceed their cost, quality, and service targets, as well as deliver excellent patient care through evidence-based data and clinical decision support capabilities.

Canine Stem Cell Therapy Industry Revenue Analysis with Impact of COVID19

Canine Stem Cell Therapy Industry Revenue Analysis with Impact of COVID19

Canine stem cell therapy is a disease-modifying therapy used for the treatment of degenerative disorders such as arthritis of hips, elbows, shoulders, etc.

Factors like rising prevalence of canine arthritis and increasing investment in research and development are expected to accentuate the growth of the canine stem cell therapy market. However, stem cell therapy is an expensive procedure as compared to other treatment options and this is impeding the growth of the market. Moreover, the lack of pet insurance will further restrain the growth of the market.

Based on type, the global canine stem cell therapy market has been segmented into autologous stem cells and allogeneic stem cells. The autologous stem cells segment accounts for more than 80% of the global canine stem cell therapy market. This segment is expected to reach $xx million by 2026 from $xx in 2019, growing at a significant rate

Based on applications, the market has been segmented into treatment and research. The treatment segment accounts for the largest share in the global canine stem cell therapy market by application.

Based on the end-user, the market has been segmented into veterinary hospitals, veterinary clinics, and veterinary research institutes. The veterinary clinics segment accounts for the largest share in the market and held more than 60% of the total market in 2018.

North America accounted for the highest share in 2018 and is expected to continue its dominance in the market throughout the forecast period. North America has the highest population of pet dogs, with around 73 million dogs in the US and over 6 million in Canada. The rising pet ownership in this region is one of the most important factors driving the growth of this market. The US accounted for around 90% of the market in 2018. The rising research and development activity in this region will also augment the growth of the canine stem cell therapy market.

Company Profiles and Competitive Intelligence:

The major players operating in this market are VetStem Biopharma, Medrego, and Magellan Stem Cells, amongst others. Most of the companies are conducting clinical trials to study the safety and efficacy of stem cells for various indication such as spinal disorders, renal disorders, etc.

About InForGrowth:

We are a market-intelligence company formed with the objective of providing clients access to the most relevant and accurate research content for their growth needs. At InForGrowth, we understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable & trusted publishing partners, we are paving way for a more simplified and relevant research.

Medtronic TYRX Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections

Medtronic TYRX Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections

Medtronic plc, the global leader in medical technology, announced new data from the landmark WRAP-IT study, showing the TYRXโ„ข Absorbable Antibacterial Envelope (TYRX Envelope) is cost effective for patients at increased risk of infections who receive cardiac implantable electronic devices (CIEDs). The analysis, newly published in Circulation: Arrhythmia and Electrophysiology, demonstrates the envelope’s cost-effectiveness compared to standard-of-care infection prevention strategies in the U.S. healthcare system.

Cost-effectiveness analyses are tools to indicate which interventions provide good value for money. This pre-specified analysis of the global WRAP-IT Trial (Worldwide Randomized Antibiotic Envelope Infection Trial) compared costs and patient outcomes between patients who received the TYRX Envelope and patients who received standard-of-care. The TYRX Envelope is cost-effective in the WRAP-IT patient population, with its ICER (incremental cost effectiveness ratio) well below the upper willingness to pay threshold of $150,000, the recommended threshold of the American College of Cardiology/American Heart Association practice guidelines on cost/value methodology.

“This analysis builds upon the results of the landmark WRAP-IT study, which showed use of the antibiotic envelope results in a significant reduction in infections, with no increase in complications,” said Bruce Wilkoff, M.D., director of Cardiac Pacing and Tachyarrhythmia Devices at Cleveland Clinic, lead author and a paid consultant to Medtronic. “These new data provide evidence that the envelope improves patient outcomes in a cost-efficient way.”

“We are committed to identifying and creating cost-effective innovations like the TYRX Envelope that add value by reducing readmission rates, lowering infection risk, and decreasing hospitalizations,” said Rob Kowal, M.D., Ph.D., chief medical officer of the Cardiac Rhythm and Heart Failure division, which is part of the Cardiac and Vascular Group at Medtronic. “During a global pandemic, reducing infections and readmissions is especially important because it means patients have fewer needs for supplemental medical care, which reduces the risk of exposure for themselves and their clinicians.”

Additional Study Results Published

Long-term results from WRAP-IT, recently published in Heart Rhythm, show that the effects of TYRX to reduce major CIED infection were sustained through three years of follow-up, which was driven by a significant reduction in pocket infections.

Further, “impact of infection” data from the study, also published in Circulation: Arrhythmia and Electrophysiology, showed that patients who experience a major CIED infection are at a greater than threefold risk of death at one year compared to patients without an infection;4 experience an additional 9-18 days in the hospital; suffer impaired quality of life through six months; and pay approximately $2,000 in out-of-pocket costs to treat the infection. TYRX is the only intervention shown to significantly reduce CIED infection in addition to standard-of-care pre-operative antibiotics.

Importantly, based on the WRAP-IT results, an international consensus statement, supported by seven medical societies (including the Heart Rhythm Society) recommends TYRX for the WRAP-IT study population and for patients with high risk factors.

Cleveland Clinic named the Medtronic TYRX Envelope one of the Top 10 Medical Innovations for 2020.

About the WRAP-IT Clinical Trial

WRAP-IT compared the incidence of major infections in 6,983 patients whose CIED implantation included the TYRX Envelope (3,495) and patients whose procedure did not (3,488), with follow up through 12 months. Primary results published in The New England Journal of Medicine demonstrated the TYRX Envelope reduced the risk of major infection by 40% in patients with CIEDs and reduced pocket infections by 61%, compared to standard of care pre-operative antibiotics. The trial also met its safety objective: the envelope did not increase the risk of complications through 12 months.

The study population included patients receiving a new cardiac resynchronization therapy defibrillator (CRT-D); and patients receiving a replacement, system revision or generator upgrade of an existing pacemaker, cardiac resynchronization therapy-pacemaker (CRT-P), implantable cardioverter defibrillator (ICD) or CRT-D. Patients with diabetes, previous history of infection, renal failure, and/or congestive heart failure also are at higher risk for CIED infections.

About the TYRXโ„ข Absorbable Antibacterial Envelope

The TYRX Envelope is an absorbable single-use device that holds a cardiac implantable electronic device or implanted neurostimulator. It is designed to stabilize the device after implantation while releasing antimicrobial agents, minocycline and rifampin, over a minimum of seven days. Constructed from a multifilament, knitted absorbable mesh, the envelope is fully absorbed by the body approximately nine weeks after implantation. The device has a one-year shelf life in the U.S., Canada, Australia and New Zealand.

In collaboration with leading clinicians, researchers and scientists worldwide, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias. The company strives to offer products and services of the highest quality that deliver clinical and economic value to healthcare consumers and providers around the world.

Translate ยป